Transparency is a critical tool that can help transform the way a nation’s health system operates. Making information available publically can improve competition among health providers, which in turn can indirectly improve quality of care.
Looking back over 2018, it is clear that the year was one of contrasts for biopharma companies. The medtech sector was fairly placid in comparison.
We are entering the Fourth Industrial Revolution (Industry 4.0) where rapid technological advances are blurring the boundaries between the physical, digital and biological worlds.
Fortinet recently conducted a survey of leaders from the College of Healthcare Information Management Executives (CHIME) to get a clearer sense of how the convergence of physical and digital security is currently being addressed within organizations around the world.
This white paper is furnished to the recipient for information purposes only. Each recipient should conduct their own investigation and analysis of any such information contained in this white paper.
That is a key question that medtech companies must address as they strive to deliver better, more engaging health care to consumers
This publication is part of the Deloitte Center for Regulatory Strategy, Americas cross-industry series on the year’s top regulatory trends.
In its 13th year, PwC Health Research Institute’s annual report highlights the forces expected to most powerfully affect the industry in 2019.
Last year in collaboration with Asia Pacific Medical Technology Association (APACMed) and A*STAR, PwC were supporting partners for the first APACMed MedTech & Digital Health workshop.
Asia is a region of stark contrasts, with approximately 4.5 billion people – some 60 percent of the world’s population – living in countries with a rich diversity of economic, political,
and demographic constituents.
The medical device industry in India is presently valued at USD 5.2 Billion and is growing at 15.8% CAGR.1 Currently, India is counted among the top 20 global medical devices market and is the 4th largest medical devices market in Asia after Japan, China and South Korea2 and is poised to grow to USD 50 billion by 2025 as per some industry estimates.
More connected and consumer-oriented than ever before, the world’s health systems are challenged to build resiliency in times of change.
Our seventh annual EvaluateMedTech® World Preview brings together many of our analyses to provide a top level insight into the expected performance of the medtech industry between now and 2024.
Guidelines for Public-Private Partnership for Non-Communicable Diseases
Public Private Partnership (PPP) for Non-Communicable Diseases (NCD) in District Hospital re
Co-location (Build, Operate and Transfer) Model of PPP